UK CORONAVIRUS CANCER MONITORING PROJECT (UKCCMP)- learning from every case of COVID-19 in cancer patients
We are a NHS clinician-led research programme that aims to monitor, safeguard and protect individuals with cancer during the coronavirus pandemic.
Our project emerged from the collective will of the oncology community in the UK. We launched on the 18th of March 2020. We were one of the first COVID-19 pandemic real-world evaluation (RWE) projects for cancer patients in the world.
We have been unique in providing direct real-time updates back to individual Cancer Centres leads, providing insight of high clinical utility to facilitate key decision makers.
Our work to safeguard, monitor and protect cancer patients has emerged from the strength, agility and resilience of UK NHS, excellence of our oncology networks (RCR, ACP, NOTCH, UK chemo board), academic institutions (Birmingham, Oxford, Leeds, UCLH, KCL) and patient networks (Macmillan and CRUK).
We are learning from every case to reduce risks to cancer patients by our innovative research programmes. We are leveraging new health record infrastructure and digital technology to accelerate COVID/cancer insights tand monitor, safeguard and protect those with cancer